Baseline use of antiarrhythmics in patients given adaptive servoventilation: SERVE-HF

Affiliations

Comment

Emir Festic. Lancet Respir Med. 2017 Jan.

. 2017 Jan;5(1):e4.

doi: 10.1016/S2213-2600(16)30429-5.

¹ Mayo Clinic College of Medicine, Jacksonville, FL, USA. Electronic address: festic.emir@mayo.edu.

No abstract available

Comment in

Baseline use of antiarrhythmics in patients given adaptive servoventilation: SERVE-HF-Authors' reply.
Eulenburg C, Wegscheider K, Woehrle H, Cowie MR. Eulenburg C, et al. Lancet Respir Med. 2017 Jan;5(1):e5. doi: 10.1016/S2213-2600(16)30428-3. Lancet Respir Med. 2017. PMID: 28000599 No abstract available.

Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis.
Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H, Cowie MR. Eulenburg C, et al. Lancet Respir Med. 2016 Nov;4(11):873-881. doi: 10.1016/S2213-2600(16)30244-2. Epub 2016 Aug 31. Lancet Respir Med. 2016. PMID: 27592224 Clinical Trial.